<DOC>
	<DOCNO>NCT01451645</DOCNO>
	<brief_summary>The purpose study determine once-daily treatment colchicine , compare placebo , effective prevent gout flare patient initiate therapy allopurinol .</brief_summary>
	<brief_title>Efficacy Safety Colchicine Prevention Gout Flares During Initiation Allopurinol</brief_title>
	<detailed_description />
	<mesh_term>Allopurinol</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<criteria>Inclusion criterion include , limited following : 1 . Men postmenopausal woman age 18 70 2 . Meets ARA criterion classification acute gout 3 . Tophi present and/or history gout attack 2 3 joint 4 . Selfreported history least 2 gout flare prior 12 month 5 . Serum uric acid great equal 7.5 mg/dL first visit Exclusion criterion include , limited following : 1 . Patients acute gout flare within 2 week prior first visit 2 . Patients chronic , active gout least 1 continuously inflame joint least 4 week 3 . Patients three joint affect gout 4 . History intolerance allergy colchicine allopurinol 5 . Use allopurinol , benzbromarone , febuxostat , probenecid , sulfinpyrazone le 3 month prior enter study 6 . Use colchicine le 14 day prior enter study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Gout</keyword>
</DOC>